Category: post-content

  • Antiepileptic drugs: review of safety of use during pregnancy

    It was whether raw intelligence, as defined by a test, should outweigh empathy, preparation, or communication – the real skills of an effective educator. As CerebrumIQ reviews pile up online, many users cerebrumiq comment not on the validity of the test’s logic puzzles or pattern recognition questions, but on the internal impact of their results.

    cerebrum iq

    The proportion of individuals in a defined population that have a disease or other health outcomes of interest at either a specified point in time (known as point prevalence) or during a specified period of time (period prevalence). Gradual loss of structure or function of nerve cells in the brain (neurons), including death of the nerve cells. Neurodegenerative diseases can influence many functions including an individual’s movement, speech, memory, intelligence and more. The disease or condition, or manifestation or symptoms thereof, for which the drug is approved.

    cerebrum iq

    Zonisamide is reported to be teratogenic in multiple animal species, both rodent and non-rodent at plasma concentrations relevant to the human therapeutic dose. NICE guidance recommends that topiramate can be used first line for myoclonic seizures and as adjunctive treatment in generalised tonic-clonic, myoclonic and focal seizures. Oxcarbazepine (brand name Trileptal) is indicated as monotherapy or adjunctive therapy in adults and children aged over 6 years of age with partial seizures with or without secondary generalised seizures. The risk of malformations with gabapentin therefore remains uncertain and further data are needed to inform our understanding. For the medicines listed below there is not enough information on their use in pregnancy to make any conclusions about their safety when used during pregnancy. It is difficult to know exactly how many people have epilepsy but it is estimated that it affects more than 600,000 people in the UK.

    Epilepsy medicines and the risks to the unborn baby

    • Moreover, we found significant correlations between DTI metrics and cognitive performances.
    • NICE guidance recommends that it may be considered for use by a tertiary epilepsy specialist when adjunctive treatment is not effective or not tolerated, and therefore its usage is limited.
    • It is a waste of effort “exercising” the brain until we have quietened and focussed our minds, and setting aside time for mental imagery and imagination will give our little grey cells a good workout.

    However, the number of exposures in the available clinical studies remains very limited and suggests that this is an area where further study would be very important. For the outcome of autism spectrum disorders, the data for lamotrigine were not completely consistent, with some studies reporting increases in the risk of autism spectrum disorders and similar outcomes, but with different estimates of the size of the increase. The prevalence of major congenital malformations varies between 1.17% and 8% in the studies, likely reflecting the different study methodologies and populations studied. However, they generally appear to support a prevalence of around 4–5% and a risk of major congenital malformations following in-utero exposure to carbamazepine monotherapy that is higher than in the general population (2–3%) and higher than that seen in women with epilepsy who are untreated. Congenital malformations reported include cleft lip or palate, cardiac malformations, neural tube defects, hypospadias, genitourinary tract defects, skeletal malformations including club foot and polydactyly and respiratory and gastrointestinal malformations.

    Key findings for phenytoin

    • The fetal growth retardation observed in the regulatory compliant studies occurred at doses approximately 1 to 5 times the human therapeutic dose.
    • However, some small, well-conducted clinical studies (less than 30 phenytoin exposures) showed a significant increased risk of serious adverse outcomes compared to control subjects including fetal hydantoin syndrome, effects on development (Rovet 1995, Arulmozhi 2006) and below average IQ (Hanson 1976, Scolnik et al 1994).
    • The risks of major congenital malformations, neurodevelopmental disorders and delay, and other reproductive toxic effects remain uncertain; the possibility of adverse effects can neither be confirmed nor ruled out.
    • Where people who receive a medicine are also more likely to have a particular risk factor then they may be more likely to develop a medical condition because of this risk factor and not because of the medicine.
    • Part of the accelerated learning model is that information in a study session is presented in ways which address as many of the “intelligences” as possible.

    Professor Robin Morris is a clinical-academic neuropsychologist at the Institute of Psychiatry, Psychology & Neuroscience (IoPPN). He has conducted research mainly into consciousness, memory and executive functioning in a range of neurological and psychiatric disorders. His work has encompassed dementia, cerebrovascular disorder, epilepsy, attention deficit hyperactivity disorder, psychosis and eating disorders. As part of his research, he developed the Cognitive Awareness Model (CAM), which provides explanations of lack of awareness of disability in patients with neurological disorder. A group of disorders characterized by delays in the development of socialization and communication skills. Parents may note symptoms as early as infancy, although the typical age of onset is before 3 years of age.

    Bipolar disorder

    cerebrum iq

    Based on this split-brain model, the behavioral aspect of cognitive-behavioral therapy would be more cerebellar and the cognitive aspects of CBT would be more cerebral. Additionally, the key to avoiding “paralysis by analysis” would be to rely less on the prefrontal cortex and more on the cerebellum. I realize now that this hypothesis isn’t 100 percent accurate; there’s more to the story. At CVI Scotland we are devoted to helping people understand cerebral visual impairments, and together working towards developing the understanding of this complex condition.

    cerebrum iq

    They were the first to discover the presence of ocular dominance columns and they determined that both right and left ocular dominance columns exist which are stimulated by visual input from the right and left eyes respectively. As you craft your story, conjure up vivid images of each word, along with the setting of your story. As described in my last post, visualization will add the unsurpassed power of your visual brain—with it vast array of visual memory circuits– to that of your storytelling brain. Notice how easily, when you’re finished creating the story, it is to recall the story and the words woven into it, especially when you remind yourself of the “moral” of your story, which gives it both importance and meaning. Cerebral hemispheres continue with development during the 9th and 10th weeks of pregnancy.